We are live on
!
Find out more
SAM
Sectoral Asset Management Portfolio holdings
AUM
$121M
1-Year Est. Return
73.47%
This Fund
S&P 500
This Quarter
Est. Return
+6.83%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$1.32B
AUM Growth
-$100M
(-7%)
Cap. Flow
-$118M
Cap. Flow
% of AUM
-8.94%
Top 10 Holdings %
Top 10 Hldgs %
27.68%
Holding
135
New
38
Increased
26
Reduced
44
Closed
22
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
OCDX
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
|
+$30.5M |
| 2 |
Arcutis Biotherapeutics
ARQT
|
+$27.4M |
| 3 |
NVTA
Invitae Corporation
NVTA
|
+$26.1M |
| 4 |
ACCD
Accolade Inc
ACCD
|
+$22.7M |
| 5 |
Vor Biopharma
VOR
|
+$22.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tandem Diabetes Care
TNDM
|
+$40.6M |
| 2 |
Acadia Pharmaceuticals
ACAD
|
+$35M |
| 3 |
Exelixis
EXEL
|
+$29.6M |
| 4 |
Labcorp
LH
|
+$28.8M |
| 5 |
AFIB
Acutus Medical Inc
AFIB
|
+$28.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 93.61% |
| 2 | Industrials | 3.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Align Technology
ALGN
$12.1B
| $18M | 1.36% |
33,225
-12,925
| -28% | -$7.14M |
|
|
FOLD
27
DELISTED
Amicus Therapeutics
FOLD
| $17.5M | 1.32% |
1,766,704
+232,100
| +15% | +$3.59M |
|
28
Agilent Technologies
A
$39.1B
| $15.8M | 1.2% |
+124,000
| New | +$15.3M |
|
29
Alnylam Pharmaceuticals
ALNY
$27.5B
| $15.5M | 1.17% |
109,746
+1,400
| +1% | +$211K |
|
|
OLK
30
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $15.3M | 1.16% |
+425,198
| New | +$14.3M |
|
31
ResMed
RMD
$30.6B
| $14.8M | 1.12% |
76,105
+9,800
| +15% | +$1.97M |
|
32
Quanterix
QTRX
$164M
| $14.2M | 1.08% |
+243,689
| New | +$16.5M |
|
|
MRTX
33
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $13.5M | 1.03% |
79,081
+5,443
| +7% | +$1.08M |
|
34
Cooper Companies
COO
$14.1B
| $13.3M | 1.01% |
+138,800
| New | +$13.2M |
|
|
HARP
35
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $13.2M | 1% |
+63,105
| New | +$12.6M |
|
|
HZNP
36
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $13.1M | 0.99% |
142,475
+133,000
| +1,404% | +$11.2M |
|
37
Natera
NTRA
$38.3B
| $13.1M | 0.99% |
128,850
+40,900
| +47% | +$4.48M |
|
38
Ultragenyx Pharmaceutical
RARE
$2.45B
| $12.8M | 0.97% |
+112,200
| New | +$15.3M |
|
39
Insmed
INSM
$21.4B
| $12.6M | 0.96% |
+370,200
| New | +$14.1M |
|
40
Centene
CNC
$30.7B
| $12.6M | 0.96% |
197,275
-59,240
| -23% | -$3.67M |
|
41
Inspire Medical Systems
INSP
$1.45B
| $12.5M | 0.95% |
+60,500
| New | +$12.9M |
|
42
InnovAge Holding
INNV
$1.54B
| $12.4M | 0.94% |
+479,794
| New | +$11.8M |
|
43
Insulet
PODD
$11.5B
| $12.4M | 0.94% |
47,354
+4,700
| +11% | +$1.26M |
|
|
HOLX
44
DELISTED
Hologic
HOLX
| $12.1M | 0.92% |
162,800
+4,500
| +3% | +$342K |
|
45
Johnson & Johnson
JNJ
$618B
| $11.9M | 0.9% |
72,500
-2,000
| -3% | -$324K |
|
46
Fate Therapeutics
FATE
$286M
| $11.7M | 0.89% |
142,500
+43,500
| +44% | +$4.17M |
|
|
ALXN
47
DELISTED
Alexion Pharmaceuticals
ALXN
| $11.7M | 0.88% |
76,226
-11,750
| -13% | -$1.82M |
|
48
DexCom
DXCM
$31.5B
| $11.5M | 0.87% |
127,652
-42,200
| -25% | -$3.96M |
|
49
BridgeBio Pharma
BBIO
$15.7B
| $11.3M | 0.86% |
183,100
+177,100
| +2,952% | +$11.6M |
|
|
PRAH
50
DELISTED
PRA Health Sciences, Inc.
PRAH
| $11.2M | 0.85% |
73,200
-63,570
| -46% | -$8.63M |
|
Similar funds
RIP
LFWA
CF
WIM
MW
AFC
AAA
TGM
Sectoral Asset Management's Q1 2021 Portfolio in Review
As of Q1 2021, Sectoral Asset Management held 135 positions worth $1.32B, down 7% from $1.42B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Sectoral Asset Management withdrew a net $118M in Q1 2021, closing 22 positions and reducing 44 holdings. Its most notable exit was Acadia Pharmaceuticals, an estimated $35M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 94% of assets, down from 97% a quarter earlier, followed by Industrials.
Against the trend, Sectoral Asset Management opened a new position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares worth $33.4M.
- Sectoral Asset Management's largest Q1 2021 buy was Ortho Clinical Diagnostics Holdings plc Ordinary Shares: 1,730,500 shares worth $33.4M.
- Sectoral Asset Management added most to TG Therapeutics in Q1 2021, an estimated $14.8M increase.
- Sectoral Asset Management's biggest Q1 2021 reduction was Tandem Diabetes Care, cutting an estimated $40.6M.
- Sectoral Asset Management fully exited Acadia Pharmaceuticals in Q1 2021, selling an estimated $35M.
- Sectoral Asset Management's ten largest holdings make up 28% of its $1.32B portfolio in Q1 2021.
- Sectoral Asset Management opened 38 new positions and closed 22 in Q1 2021.
- Sectoral Asset Management's portfolio value fell 7% quarter-over-quarter to $1.32B.
Based on Sectoral Asset Management's 13F filing for Q1 2021, filed 14 May 2021.